glycopyrrolate 1 mg/5 mL recall: Sterility Concern
glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1
Why was glycopyrrolate 1 mg/5 mL recalled?
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 36-247022, Exp 08/07/2023; 36-239877, Exp 07/13/2023; 36-241448, Exp 07/20/2023; 36-251782, Exp 08/29/2023
- Product
- glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Quantity
- 770 Syringes
- Distribution
- Nationwide in the USA
- Recall date
- August 9, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)